Effect of H1 antihistamines upon the central nervous system

Journal of Investigational Allergology and Clinical Immunology

Volumn 16, Issue SUPPL. 1, 2006, Pages 24-28

  Montoro, J ^a   Sastre, J ^b   Bartra, J ^c   Del Cuvillo, A ^d   Davila I ^e   Jauregui I ^f   Mullol, J ^c   Valero, A L ^c  

^a HOSPITAL DE LA PLANA   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Clinica Dr Lobaton   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^f HOSPITAL DE BASURTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CETIRIZINE; CHLORPHENIRAMINE; DESLORATADINE; DEXCHLORPHENIRAMINE; DOXEPIN; EBASTINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDRAZINE; PLACEBO; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; DROWSINESS; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG MECHANISM; DRUG PENETRATION; DRUG RECEPTOR BINDING; FATIGUE; HUMAN; PEDIATRICS; POSITRON EMISSION TOMOGRAPHY; PSYCHOMOTOR ACTIVITY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; ADULT; BLOOD BRAIN BARRIER; CHILD; DRUG EFFECT; HYPOTHALAMUS; PHYSIOLOGY; SLEEP STAGE;

ADULT; BLOOD-BRAIN BARRIER; CHILD; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPOTHALAMUS; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; SLEEP STAGES;

EID: 33846096396     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Simons FE. Advances in H1-Antihistamines. N Engl J Med 2004; 351: 2203-2217.
2. Holgate ST, Canonica GW, Simons FER, Taglialatela M, Tharp M, Timmerman H, Yanai K. Consensus group on newgeneration antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003; 33: 1305-1324.
3. Chen C, Hanson E, Watson JW, Lee JS. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1- antagonists. Drug Metab Disp 2003; 31: 312-318.
4. Blandina P, Efoudebe M, Cenni G, Mannaioni P, Passani MB. Acetylcholine, histamine and cognition: two sides of the same coin. Learn Mem 2004; 11: 1-8.
5. Korotkowa TM, Sergeeva OA, Ponomarenko AA, Haas HL. Histamine excites noradrenergic neurons in locus coeruleus in rats. Neuropharmacology 2005; 49:129-134.
6. Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (Orexin/Hypocretin, Histamine and Noradrenaline). J Neurosci 2002; 22:8850-8859.
7. Kurose Y, Terashima Y. Histamine regulates food intake through modulating noradrenaline release in the paraventricular nucleus. Brain Res 1999; 828:115-118.
8. Bealer SL, Crowley WR. Stimulation of central and systemic oxytocin release by histamine in the paraventricular hypothalamic nucleus: evidence for an interaction with norepinephrine. Endocrinology 1999; 140: 1158-1164.
9. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S, Ido T, Itoh M, Sasaki H, Watanabe T, Yanai K. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emisión tomography (PET): A comparative study of ebastine, a second generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 2001; 52: 501-509.
10. Mochizuki H, Kimura Y, Ishii K, Oda K, Sasaki T, Tashiro M, Yanai K, Ishiwata K. Quantitative measurement of histamine H1 receptors in human brains by PET and C-11 doxepin. Nucl Med Biol 2004; 31:165-171.
11. Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using C-11 doxepin positron emission tomography. J Clin Pharmacol 2004; 44: 890-900.
12. Okamura N, Yanai K, Higuchi M, Sakai J, Iwata R, Ido T, Sasaki H, Watanabe T, Itoh M. Functional neuroimaging of cognition impaired by a classical antihistamine, dchlorpheniramine. Br J Pharmacol 2000; 129: 115-123.
13. Morgan GE, Mikhail MS. Neurofisiología y anestesia. In El Manual Moderno (Ed), Anestesiología Clínica. 2003; 573- 588.
14. Coull JT, Nobre AC. Where and when to pay attention: the neural systems for directing attention to spatial locations and to time intervals as revealed by both PET and fMRI. J Neurosci 1998; 18: 7426-7435.
15. Naito E, Kinomura S, Geyer S, Kawashima R, Roland PE, Zilles K. Fast reaction to different sensory modalities activates common fields in the motor areas, but the anterior cingulated cortex is involved in the speed of reaction. J Neurophysiol 2000; 83: 1701-1709.
16. Stevenson J, Cornah D, Evrard P, Vanderheyden V, Billard C, Bax M, Van Hout A; ETAC Study Group. Long-term evaluation of the impact of the H1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis. Pediatr Res 2002; 52: 251-257.
17. Baena-Cagnani CE. Safety and tolerability of treatments for allergic rhinitis in children. Drug Saf 2004; 27: 883-898.
18. Potter PC; Paediatric Levocetirizine Study Group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol 2005; 95: 175-180.
19. Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW, Shek LP. Central nervous system side effects of first and second generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics 2004; 113: e116-e121.
20. Ridout F, Shamsi Z, Meadows R, Johnson S, Hindmarch I. A single-center, randomized, double-blind, placebocontrolled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg, alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Clin Ther 2003; 25: 1518-1538.
21. Zimatkin SM, Anichtchik OV. Alcohol-histamine interactions. Alcohol Alcohol 1999; 34: 141-147.
22. Weiler JM, Bloomfield JR, Woodworth GG, Grant AR, Layton TA, Brown TL, Mc Kenzie DR, Baker TW, Watson GS. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. Ann Intern Med 2000; 132: 354- 363.
23. Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 2002; 32: 133-139.
24. Shamsi Z, Kimber S, Hindmarch I. An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 2001; 56: 865-871.
25. Simons FE, Fraser TG, Maher J, Pillay N, Simons KJ. Central nervous system effects of H1-receptor antagonists in the elderly. Ann Allergy Asthma Immunol 1999; 82:157- 160.
26. Simons FE, Fraser TG, Reggin JD, Simons KJ. Individual differences in central nervous system response to antihistamines (H1-receptor antagonists). Ann Allergy Asthma Immunol 1995; 75: 507-514.
27. Hindmarch I, Johnson S, Meadows R, Kirkpatrick T, Shamsi Z. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and wheal and flare. Curr Med Res Opin 2001; 17: 241-255.
28. Barbanoj MJ, García-Gea C, Morte A, Izquierdo I, Pérez I, Jané F. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. Neuropsychobiology 2004; 50: 311-321.
29. Verster C, Volkerts ER, van Oosterwijck AW, Aarab M, Bijtjes SI, De Weert AM, Eijken EJ, Verbaten MN. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psicomotor performance, and mood. J Allergy Clin Immunol 2003; 111: 623-627.
30. Gandon JM, Allain H. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers. Br J Clin Pharmacol 2002; 54: 51-58.